Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Leteurtre

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Endocrine-Related Cancer|August 3, 2022
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC studyJulien Hadoux, Thomas Walter, Christina Kanaan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2015
Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic StricturesMathurin Fumery, Guillaume Pineton de Chambrun, Carmen Stefanescu, et al.
The Journal of Clinical Investigation|December 3, 2013
TTC7A mutations disrupt intestinal epithelial apicobasal polarityAmélie E Bigorgne, Henner F Farin, Roxane Lemoine, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2018
Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluationKarine Renaudin, Sarra Smati, Matthieu Wargny, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2021
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN networkJulien Hadoux, Christina Kanaan, Alice Durand, et al.
Thyroid : Official Journal of the American Thyroid Association|October 19, 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF NetworkArnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
Plos Biology|December 12, 2025
Derepression of the epithelial transcription factor GRHL2 promotes direct hepatocyte-to-cholangiocyte transdifferentiationLudivine Vasseur, Céline Gheeraert, Julie Dubois-Chevalier, et al.
Inflammatory Bowel Diseases|July 17, 2014
Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular studyMagali Svrcek, Gael Piton, Jacques Cosnes, et al.
Gastroenterology|January 21, 2014
A histologic scoring system for prognosis of patients with alcoholic hepatitisJosé Altamirano, Rosa Miquel, Aezam Katoonizadeh, et al.
Nature Medicine|December 9, 2024
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver diseaseVioleta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Endocrine-Related Cancer|August 3, 2022
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC studyJulien Hadoux, Thomas Walter, Christina Kanaan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2015
Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic StricturesMathurin Fumery, Guillaume Pineton de Chambrun, Carmen Stefanescu, et al.
The Journal of Clinical Investigation|December 3, 2013
TTC7A mutations disrupt intestinal epithelial apicobasal polarityAmélie E Bigorgne, Henner F Farin, Roxane Lemoine, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2018
Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluationKarine Renaudin, Sarra Smati, Matthieu Wargny, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2021
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN networkJulien Hadoux, Christina Kanaan, Alice Durand, et al.
Thyroid : Official Journal of the American Thyroid Association|October 19, 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF NetworkArnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière, et al.
Plos Biology|December 12, 2025
Derepression of the epithelial transcription factor GRHL2 promotes direct hepatocyte-to-cholangiocyte transdifferentiationLudivine Vasseur, Céline Gheeraert, Julie Dubois-Chevalier, et al.
Inflammatory Bowel Diseases|July 17, 2014
Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular studyMagali Svrcek, Gael Piton, Jacques Cosnes, et al.
Gastroenterology|January 21, 2014
A histologic scoring system for prognosis of patients with alcoholic hepatitisJosé Altamirano, Rosa Miquel, Aezam Katoonizadeh, et al.
Nature Medicine|December 9, 2024
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver diseaseVioleta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Pageof 14